MAM
ALDR

Melqart Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Melqart Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,680,000
Closed -$50.5M – 46
2019
Q3 		$50.5M Buy
+2,680,000
New +$30.7M 4.59% 8

Melqart Asset Management's ALDR Position: Q4 2019 in Review

Melqart Asset Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 2,680,000 shares — an estimated $50.5M sold.

Melqart Asset Management first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $50.5M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Melqart Asset Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Melqart Asset Management sold 2,680,000 Alder Biopharmaceuticals shares in Q4 2019, an estimated $50.5M.
  • Melqart Asset Management first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Melqart Asset Management's Alder Biopharmaceuticals position peaked at $50.5M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Melqart Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.